Bristol-Myers Squibb Co
NYSE:BMY
Net Margin
Bristol-Myers Squibb Co
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | US |
| Market Cap | 88.8B USD |
| Net Margin |
18%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Net Margin |
-79%
|
| Country | US |
| Market Cap | 741.6B USD |
| Net Margin |
15%
|
| Country | DK |
| Market Cap | 4T DKK |
| Net Margin |
36%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Net Margin |
-4%
|
| Country | JP |
| Market Cap | 82T JPY |
| Net Margin |
3%
|
| Country | US |
| Market Cap | 348B USD |
| Net Margin |
50%
|
| Country | US |
| Market Cap | 327.1B USD |
| Net Margin |
1%
|
| Country | UK |
| Market Cap | 187B GBP |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 182B CHF |
| Net Margin |
32%
|
| Country | CH |
| Market Cap | 175.9B CHF |
| Net Margin |
20%
|
Profitability Report
View the profitability report to see the full profitability analysis for Bristol-Myers Squibb Co.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Bristol-Myers Squibb Co's most recent financial statements, the company has Net Margin of 17.8%.
You don't have any saved screeners yet
